
Humira is a monoclonal antibody that binds to TNF alpha, inactivates TNF alpha receptors, and inhibits inflammation. Neonatal Fc receptors can mediate the transcytosis of Humira–TNF alpha complex structures and process them toward degradation pathways, which reduces the therapeutic effect of Humira. Allowing the Humira–TNF alpha complex structures to dissociate to Humira and soluble TNF alpha in the early endosome to enable Humira recycling is crucial. We used the cytoplasmic pH (7.4), the early endosomal pH (6.0), and pKa of histidine side chains (6.0–6.4) to mutate the residues of complementarity-determining regions with histidine. Our engineered Humira (W1-Humira) can bind to TNF alpha in plasma at neutral pH and dissociate from the TNF alpha in the endosome at acidic pH. We used the constant-pH molecular dynamics, Gaussian accelerated molecular dynamics, two-dimensional potential mean force profiles, and in vitro methods to investigate the characteristics of W1-Humira. Our results revealed that the proposed Humira can bind TNF alpha with pH-dependent affinity in vitro. The W1-Humira was weaker than wild-type Humira at neutral pH in vitro, and our prediction results were close to the in vitro results. Furthermore, our approach displayed a high accuracy in antibody pH-dependent binding characteristics prediction, which may facilitate antibody drug design. Advancements in computational methods and computing power may further aid in addressing the challenges in antibody drug design.
Cytoplasm, Protein Conformation, Normal Distribution, Receptors, Fc, In Vitro Techniques, Molecular Dynamics Simulation, Microbiology, Article, antibody, Humans, Computer Simulation, Histidine, Inflammation, Tumor Necrosis Factor-alpha, Histocompatibility Antigens Class I, Adalimumab, Antibodies, Monoclonal, Hydrogen-Ion Concentration, Gaussian accelerated molecular dynamics, anti-TNF alpha, QR1-502, Drug Design, constant-pH molecular dynamics, molecular simulations, Protein Binding
Cytoplasm, Protein Conformation, Normal Distribution, Receptors, Fc, In Vitro Techniques, Molecular Dynamics Simulation, Microbiology, Article, antibody, Humans, Computer Simulation, Histidine, Inflammation, Tumor Necrosis Factor-alpha, Histocompatibility Antigens Class I, Adalimumab, Antibodies, Monoclonal, Hydrogen-Ion Concentration, Gaussian accelerated molecular dynamics, anti-TNF alpha, QR1-502, Drug Design, constant-pH molecular dynamics, molecular simulations, Protein Binding
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
